메뉴 건너뛰기




Volumn 13, Issue 1, 2011, Pages 51-56

Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection

Author keywords

Cardiovascular risk prevention; Dyslipidemia; HIV; Lipodystrophy; Review; Statin therapy

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; ATORVASTATIN; FIBRIC ACID DERIVATIVE; FISH OIL; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; MEVINOLIN; NICOTINIC ACID; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OMEGA 3 FATTY ACID; PIOGLITAZONE; PRAVASTATIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ROSIGLITAZONE; ROSUVASTATIN; SIMVASTATIN; STAVUDINE; TENOFOVIR; THYMIDINE DERIVATIVE; ZIDOVUDINE;

EID: 79551562916     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0152-1     Document Type: Article
Times cited : (52)

References (35)
  • 1
    • 0030966136 scopus 로고    scopus 로고
    • Soluble adhesion molecules and endothelial cell damage in HIV infected patients
    • 1:CAS:528:DyaK2sXislOjs7g%3D 9134636
    • M Seigneur J Constans A Blann, et al. 1997 Soluble adhesion molecules and endothelial cell damage in HIV infected patients Thromb Haemost 77 646 1:CAS:528:DyaK2sXislOjs7g%3D 9134636
    • (1997) Thromb Haemost , vol.77 , pp. 646
    • Seigneur, M.1    Constans, J.2    Blann, A.3
  • 3
    • 0031902426 scopus 로고    scopus 로고
    • Plasma hypercoagulability is correlated to plasma HIV load
    • 1:CAS:528:DyaK1cXkslWmsbc%3D 9684818
    • M Karmochkine A Ankri V Calvez, et al. 1998 Plasma hypercoagulability is correlated to plasma HIV load Thromb Haemost 80 208 1:CAS:528:DyaK1cXkslWmsbc%3D 9684818
    • (1998) Thromb Haemost , vol.80 , pp. 208
    • Karmochkine, M.1    Ankri, A.2    Calvez, V.3
  • 4
    • 70249090072 scopus 로고    scopus 로고
    • Preclinical atherosclerosis due to HIV infection: Carotid intima-medial thickness measurements from the FRAM study
    • 10.1097/QAD.0b013e32832d3b85 19455012
    • C Grunfeld JA Delaney C Wanke, et al. 2009 Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study AIDS 23 1841 10.1097/QAD.0b013e32832d3b85 19455012
    • (2009) AIDS , vol.23 , pp. 1841
    • Grunfeld, C.1    Delaney, J.A.2    Wanke, C.3
  • 5
    • 52249121996 scopus 로고    scopus 로고
    • Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
    • 10.1097/QAD.0b013e328300581d 18670221
    • RC Kaplan LA Kingsley SJ Gange, et al. 2008 Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men AIDS 22 1615 10.1097/QAD.0b013e328300581d 18670221
    • (2008) AIDS , vol.22 , pp. 1615
    • Kaplan, R.C.1    Kingsley, L.A.2    Gange, S.J.3
  • 6
    • 67651065515 scopus 로고    scopus 로고
    • Association of C-Reactive Protein and HIV Infection with Acute Myocardial Infarction
    • 1:CAS:528:DC%2BD1MXns1ertb8%3D 10.1097/QAI.0b013e3181a9992c 19387353
    • VA Triant JB Meigs SK Grinspoon 2009 Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction J Acquir Immune Defic Syndr 51 268 1:CAS:528:DC%2BD1MXns1ertb8%3D 10.1097/QAI.0b013e3181a9992c 19387353
    • (2009) J Acquir Immune Defic Syndr , vol.51 , pp. 268
    • Triant, V.A.1    Meigs, J.B.2    Grinspoon, S.K.3
  • 8
    • 63149119125 scopus 로고    scopus 로고
    • HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction
    • 10.1097/QAD.0b013e328325a87c 19177019
    • D Francisci S Giannini F Baldelli, et al. 2009 HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction AIDS 23 589 10.1097/QAD.0b013e328325a87c 19177019
    • (2009) AIDS , vol.23 , pp. 589
    • Francisci, D.1    Giannini, S.2    Baldelli, F.3
  • 9
    • 47649098334 scopus 로고    scopus 로고
    • State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS:executive summary
    • This is an excellent discussion of relevant articles reviewing the state of the science on this subject
    • •• Grinspoon, SK, Grunfeld, C, Kotler, DP, et al. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS:executive summary. Circulation 2008; 118:198). This is an excellent discussion of relevant articles reviewing the state of the science on this subject.
    • (2008) Circulation , vol.118 , pp. 198
    • Grinspoon, S.K.1    Grunfeld, C.2    Kotler, D.P.3
  • 10
    • 33847073815 scopus 로고    scopus 로고
    • Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population
    • Mondy, K.; Overton, E.T.; Grubb, J, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clinical Infections Dis., 2007, 44, 726-34.
    • (2007) Clinical Infections Dis. , vol.44 , pp. 726-734
    • Mondy, K.1    Overton, E.T.2    Grubb, J.3
  • 11
    • 77953747966 scopus 로고    scopus 로고
    • Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults
    • 10.1089/met.2009.0094 20235745
    • CR Pullinger BE Aouizerat C Gay, et al. 2010 Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults Metab Syndr Relat Disord. 8 3 279 86 10.1089/met.2009.0094 20235745
    • (2010) Metab Syndr Relat Disord. , vol.8 , Issue.3 , pp. 279-86
    • Pullinger, C.R.1    Aouizerat, B.E.2    Gay, C.3
  • 12
    • 0037032941 scopus 로고    scopus 로고
    • Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: Results of a substudy from a comparative trial
    • DOI 10.1097/00002030-200212060-00010
    • V Joly P Flandre V Meiffredy, et al. 2002 Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial AIDS 16 2447 1:CAS:528:DC%2BD38XptFKgu7s%3D 10.1097/00002030-200212060-00010 12461419 (Pubitemid 35471693)
    • (2002) AIDS , vol.16 , Issue.18 , pp. 2447-2454
    • Joly, V.1    Flandre, P.2    Meiffredy, V.3    Leturque, N.4    Harel, M.5    Aboulker, J.-P.6    Yeni, P.7
  • 13
    • 33750227103 scopus 로고    scopus 로고
    • A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy
    • DOI 10.1097/01.aids.0000247574.33998.03, PII 0000203020061024000006
    • GJ Moyle CA Sabin J Cartledge, et al. 2006 A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy AIDS 20 2043 1:CAS:528:DC%2BD28XhtV2rsrnE 10.1097/01.aids. 0000247574.33998.03 17053350 (Pubitemid 44611057)
    • (2006) AIDS , vol.20 , Issue.16 , pp. 2043-2050
    • Moyle, G.J.1    Sabin, C.A.2    Cartledge, J.3    Johnson, M.4    Wilkins, E.5    Churchill, D.6    Hay, P.7    Fakoya, A.8    Murphy, M.9    Scullard, G.10    Leen, C.11    Reilly, G.12
  • 14
    • 2442593038 scopus 로고    scopus 로고
    • In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3 T3 and human preadipocytes or adipocytes
    • Apr 9 Epub 2004 Jan 13
    • El Hadri K, Glorian M, Monsempes C, Dieudonné MN, et al. In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3 T3 and human preadipocytes or adipocytes. Chem. 2004 Apr 9;279(15):15130-41. Epub 2004 Jan 13.
    • (2004) Chem , vol.279 , Issue.15 , pp. 15130-15141
    • El Hadri, K.G.1
  • 15
    • 33845417218 scopus 로고    scopus 로고
    • Jan Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study
    • Biol Res Nurs. 2007 Jan;8(3):177-85. Effects of high-intensity endurance and resistance exercise on HIV metabolic abnormalities: a pilot study. Robinson FP, Quinn LT, Rimmer JH.
    • (2007) Biol Res Nurs. , vol.8 , Issue.3 , pp. 177-185
    • Robinson, F.P.1    Quinn, L.T.2    Rimmer, J.H.3
  • 16
    • 2342589533 scopus 로고    scopus 로고
    • Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: The MITOX Extension Study
    • DOI 10.1097/00002030-200404300-00011
    • A Martin DE Smith A Carr, et al. 2004 Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study AIDS 18 1029 1:CAS:528:DC%2BD2cXkvFKhsr8%3D 10.1097/00002030-200404300-00011 15096806 (Pubitemid 38591194)
    • (2004) AIDS , vol.18 , Issue.7 , pp. 1029-1036
    • Martin, A.1    Smith, D.E.2    Carr, A.3    Ringland, C.4    Amin, J.5    Emery, S.6    Hoy, J.7    Workman, C.8    Doong, N.9    Freund, J.10    Cooper, D.A.11
  • 17
    • 1642456562 scopus 로고    scopus 로고
    • Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study
    • DOI 10.1086/380790
    • GA McComsey DJ Ward SM Hessenthaler, et al. 2004 Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study Clin Infect Dis 38 263 1:CAS:528:DC%2BD2cXhtFSgu74%3D 10.1086/380790 14699460 (Pubitemid 38113036)
    • (2004) Clinical Infectious Diseases , vol.38 , Issue.2 , pp. 263-270
    • McComsey, G.A.1    Ward, D.J.2    Hessenthaler, S.M.3    Sension, M.G.4    Shalit, P.5    Lonergan, J.T.6    Fisher, R.L.7    Williams, V.C.8    Hernandez, J.E.9
  • 18
    • 43649093166 scopus 로고    scopus 로고
    • Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication
    • Apr Epub 2008 Jan 20
    • Amet T, Nonaka M, Dewan MZ, et al. Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication. Microbes Infect. 2008 Apr;10(5):471-80. Epub 2008 Jan 20.
    • (2008) Microbes Infect , vol.10 , Issue.5 , pp. 471-480
    • Amet, T.1    Nonaka, M.2    Dewan, M.Z.3
  • 19
    • 0042832397 scopus 로고    scopus 로고
    • Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
    • DOI 10.1086/378131
    • MP Dube JH Stein JA Aberg, et al. 2003 Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group Clin Infect Dis 37 613 10.1086/378131 12942391 (Pubitemid 37100800)
    • (2003) Clinical Infectious Diseases , vol.37 , Issue.5 , pp. 613-627
    • Dube, M.P.1    Stein, J.H.2    Aberg, J.A.3    Fichtenbaum, C.J.4    Gerber, J.G.5    Tashima, K.T.6    Henry, W.K.7    Currier, J.S.8    Sprecher, D.9    Glesby, M.J.10
  • 20
    • 0141612021 scopus 로고    scopus 로고
    • Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams
    • 1:CAS:528:DC%2BD3sXnvVSht7o%3D 10.1016/S0002-9149(03)00779-3 12948873
    • HB Brewer Jr 2003 Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams Am J Cardiol 92 23K 1:CAS:528:DC%2BD3sXnvVSht7o%3D 10.1016/S0002-9149(03)00779-3 12948873
    • (2003) Am J Cardiol , vol.92
    • Brewer Jr., H.B.1
  • 23
    • 51749084593 scopus 로고    scopus 로고
    • Treatment of altered body composition in HIV-associated lipodystrophy: Comparison of rosiglitazone, pravastatin, and recombinant human growth hormone
    • Jul-Aug
    • Macallan DC, Baldwin C, Mandalia S, et al. Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone. HIV Clin Trials. 2008 Jul-Aug; 9(4):254-68.
    • (2008) HIV Clin Trials , vol.9 , Issue.4 , pp. 254-268
    • MacAllan, D.C.1    Baldwin, C.2    Mandalia, S.3
  • 24
    • 34250212715 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
    • 1:CAS:528:DC%2BD2sXms1SisrY%3D 10.1056/NEJMoa072761 17517853
    • SE Nissen K Wolski 2007 Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2457 1:CAS:528:DC%2BD2sXms1SisrY%3D 10.1056/NEJMoa072761 17517853
    • (2007) N Engl J Med , vol.356 , pp. 2457
    • Nissen, S.E.1    Wolski, K.2
  • 25
    • 34249896151 scopus 로고    scopus 로고
    • Use of thiazolidinediones in HIV-infected patients: What have we learned?
    • DOI 10.1086/518008
    • S Grinspoon 2007 Use of Thiazolidinediones in HIV-Infected Patients: What Have We Learned? J Infect Dis 195 1731 1:CAS:528:DC%2BD2sXnt1Gksb0%3D 10.1086/518008 17492586 (Pubitemid 46870243)
    • (2007) Journal of Infectious Diseases , vol.195 , Issue.12 , pp. 1731-1733
    • Grinspoon, S.1
  • 26
    • 56749131189 scopus 로고    scopus 로고
    • Effect of rosiglitazone on peroxisome proliferatoractivated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction
    • 1:CAS:528:DC%2BD1MXhtFSltbY%3D 10.1086/593179 18954260
    • PW Mallon R Sedwell G Rogers, et al. 2008 Effect of rosiglitazone on peroxisome proliferatoractivated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction J Infect Dis 198 1794 1:CAS:528:DC%2BD1MXhtFSltbY%3D 10.1086/593179 18954260
    • (2008) J Infect Dis , vol.198 , pp. 1794
    • Mallon, P.W.1    Sedwell, R.2    Rogers, G.3
  • 27
    • 42149084966 scopus 로고    scopus 로고
    • Effect of pioglitazone on HIV-1-related lipodystrophy: A randomized double-blind placebo-controlled trial (ANRS 113)
    • 1:CAS:528:DC%2BD1cXksVegsb0%3D 18389900
    • L Slama E Lanoy MA Valantin, et al. 2008 Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113) Antivir Ther 13 67 1:CAS:528:DC%2BD1cXksVegsb0%3D 18389900
    • (2008) Antivir Ther , vol.13 , pp. 67
    • Slama, L.1    Lanoy, E.2    Valantin, M.A.3
  • 28
    • 77953707169 scopus 로고    scopus 로고
    • The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: A meta-analysis of randomized trials
    • 10.1186/1471-2334-10-183 20573187
    • SH Sheth RJ Larson 2010 The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials BMC Infect Dis. 10 183 10.1186/1471-2334-10-183 20573187
    • (2010) BMC Infect Dis. , vol.10 , pp. 183
    • Sheth, S.H.1    Larson, R.J.2
  • 29
    • 77950800360 scopus 로고    scopus 로고
    • Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism
    • Apr Epub 2009 Dec 8
    • Hansen BR, Haugaard SB, Jensen FK, et al. Long-term high-physiological- dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism. HIV Med. 2010 Apr;11(4):266-75. Epub 2009 Dec 8.
    • (2010) HIV Med. , vol.11 , Issue.4 , pp. 266-275
    • Hansen, B.R.1    Haugaard, S.B.2    Jensen, F.K.3
  • 30
    • 77649226509 scopus 로고    scopus 로고
    • Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: A randomized placebo-controlled trial with a safety extension
    • 1:CAS:528:DC%2BC3cXisFejur4%3D 10.1097/QAI.0b013e3181cbdaff 20101189
    • J Falutz D Potvin JC Mamputu, et al. 2010 Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension J Acquir Immune Defic Syndr. 53 3 311 22 1:CAS:528:DC%2BC3cXisFejur4%3D 10.1097/QAI.0b013e3181cbdaff 20101189
    • (2010) J Acquir Immune Defic Syndr. , vol.53 , Issue.3 , pp. 311-22
    • Falutz, J.1    Potvin, D.2    Mamputu, J.C.3
  • 31
    • 67449093468 scopus 로고    scopus 로고
    • Expert Tesamorelin, a human growth hormone releasing factor analogue
    • 1:CAS:528:DC%2BD1MXitlWrtrs%3D 10.1517/13543780802707658
    • Y Wang B Tomlinson 2009 Expert Tesamorelin, a human growth hormone releasing factor analogue Opin Investig Drugs. 18 3 303 10 1:CAS:528: DC%2BD1MXitlWrtrs%3D 10.1517/13543780802707658
    • (2009) Opin Investig Drugs. , vol.18 , Issue.3 , pp. 303-10
    • Wang, Y.1    Tomlinson, B.2
  • 32
    • 58149273826 scopus 로고    scopus 로고
    • Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation
    • 1:CAS:528:DC%2BD1cXhtVekt73F 10.1097/QAD.0b013e32830a5058 18690162
    • J Falutz S Allas JC Mamputu, et al. 2008 Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation AIDS. 22 14 1719 28 1:CAS:528:DC%2BD1cXhtVekt73F 10.1097/QAD.0b013e32830a5058 18690162
    • (2008) AIDS , vol.22 , Issue.14 , pp. 1719-28
    • Falutz, J.1    Allas, S.2    Mamputu, J.C.3
  • 33
    • 0026566740 scopus 로고
    • Endothelial cell dysfunction in HIV infection
    • 1:STN:280:DyaK387it1SqtQ%3D%3D 1531074
    • A Lafeuillade MC Alessi I Poizot-Martin, et al. 1992 Endothelial cell dysfunction in HIV infection J Acquir Immune Defic Syndr. 5 2 127 31 1:STN:280:DyaK387it1SqtQ%3D%3D 1531074
    • (1992) J Acquir Immune Defic Syndr. , vol.5 , Issue.2 , pp. 127-31
    • Lafeuillade, A.1    Alessi, M.C.2    Poizot-Martin, I.3
  • 34
    • 70350118312 scopus 로고    scopus 로고
    • Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients
    • S Ferraro S Paolillo M Gargiulo, et al. 2009 Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients G Ital Cardiol (Rome). 10 9 596 601
    • (2009) G Ital Cardiol (Rome). , vol.10 , Issue.9 , pp. 596-601
    • Ferraro, S.1    Paolillo, S.2    Gargiulo, M.3
  • 35
    • 79551547470 scopus 로고    scopus 로고
    • September 1 Untreated HIV Infection and Large and Small Artery ElasticityJason V. Baker, MD, MS, † Daniel Duprez, MD, PhD,† Joshua Rapkin, MS,‡ Katherine Huppler Hullsiek, PhD,‡ Harrison Quick, BS,‡ Richard Grimm, MD, PhD, James D. Neaton, PhD, and Keith Henry, MD
    • J Acquir Immune Defic Syndr. 2009 September 1; 52(1): 25-31. Untreated HIV Infection and Large and Small Artery ElasticityJason V. Baker, MD, MS, † Daniel Duprez, MD, PhD,† Joshua Rapkin, MS,‡ Katherine Huppler Hullsiek, PhD,‡ Harrison Quick, BS,‡ Richard Grimm, MD, PhD, James D. Neaton, PhD, and Keith Henry, MD
    • (2009) J Acquir Immune Defic Syndr , vol.52 , Issue.1 , pp. 25-31


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.